At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 7, 2026 at 17:42 ET
Two insiders at Immunome (CMO and a director) sold shares totaling $2.19M in open-market transactions over a 7-day window. The sales represent less than 0.1% of the company's $2.7B market cap, making them routine and non-material. No specific catalyst or pattern suggests informed selling.
- Total open-market sales of $2.19M by two insiders (CMO Robert Lechleider and Director Isaac Barchas) over a 7-day window ending July 2, 2026.
- Sales represent approximately 0.08% of Immunome's $2.7B market cap, well below the 0.1% materiality threshold.
- CMO Lechleider also exercised 110,000 stock options (55,000 at $0 and 55,000 at $8.73) concurrently with the sales, a common pattern to cover tax obligations or generate liquidity.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access